← Back to Directory

Thyroid Red Light Therapy (Topical)

Thyroid Photobiomodulation, Thyroid PBM, Low-Level Laser Therapy for Thyroid

Visual ViewRaw Data

Meta Information

ID:thyroid-red-light-therapy
Name:Thyroid Red Light Therapy
Schema Version:1.5

Alternate Names

  • Thyroid Photobiomodulation
  • Thyroid PBM
  • Low-Level Laser Therapy for Thyroid

Active Compound

null

Intervention Type

device

Delivery

Route:
topical_skin
Scope:
  • local

Is Skin Health

False

Regulatory Status

  • us:general_wellness_device

Indication

Focus:
disease_treatment
Description:
Used to treat autoimmune thyroiditis (Hashimoto's disease) by potentially reducing inflammation and improving thyroid function.

Typical Protocol

  • Typical protocols involve applying a near-infrared light device (830-850 nm) to the neck over the thyroid for 10-20 minutes per session.
  • Sessions are often performed 1-2 times per week for several weeks, as guided by clinical studies.

Expected Cost Mean

Low Cost:
200
High Cost:
1500
Cost Type:
equipment
Description:
One-time purchase of an at-home near-infrared light therapy device; not covered by insurance.

Summary

Thyroid red light therapy, or photobiomodulation, uses specific wavelengths of near-infrared light to stimulate cellular activity within the thyroid gland. The proposed mechanism involves enhancing mitochondrial function, which may increase ATP production, reduce oxidative stress, and decrease inflammation. In the context of autoimmune thyroiditis, this could potentially improve thyroid hormone production and reduce antibody levels, sometimes leading to a reduction in required medication dosage.

Purpose

Using near-infrared light to potentially improve function in autoimmune thyroiditis.

Card Summary

A non-invasive therapy using near-infrared light on the neck to potentially improve thyroid function and reduce antibodies in autoimmune thyroiditis.

Drug Class

null

Drugs In Class

Empty Array

Impact

Score:
4.5
Justification:
Targeted benefit for autoimmune thyroiditis with some evidence for improved function and antibody reduction.

Evidence

Grade:
B
Score:
5.5
Justification:
Based on a small number of human RCTs showing promise for Hashimoto's disease.

Safety

Score:
3
Justification:
Generally safe, but requires eye protection and caution with existing thyroid nodules.

Flags

  • Must be used with caution in individuals with known thyroid nodules or cancer.
  • Improper use or device settings could cause skin burns or eye damage.
  • Consult a physician before altering thyroid medication based on therapy results.
  • Evidence is still emerging and long-term effects are not well-studied.

Verdict

A promising but experimental therapy for autoimmune thyroiditis needing more research.

Created

2026-05-01T08:27:44.273481Z

Ai Model

Gemini 2.5 Pro (High)